Multiple sclerosis: iron mapping, predicting response to interferon-β and effects of oral teriflunomide

M Strupp¹

Affiliations

¹ Department of Neurology and IFBLMU, Campus Grosshadern, University Hospital Munich, Marchioninistr. 15, 81377, Munich, Germany. Michael.strupp@med.uni-muenchen.de

Comment

M Strupp. J Neurol. 2011 Dec.

. 2011 Dec;258(12):2302-4.

doi: 10.1007/s00415-011-6322-4.

M Strupp¹

¹ Department of Neurology and IFBLMU, Campus Grosshadern, University Hospital Munich, Marchioninistr. 15, 81377, Munich, Germany. Michael.strupp@med.uni-muenchen.de

No abstract available

Comment on

MR brain iron mapping in MS: a potential neurodegenerative marker or just another technique?
Rovira A, Montalban X. Rovira A, et al. Neurology. 2011 Nov 1;77(18):1660-1. doi: 10.1212/WNL.0b013e318236f120. Epub 2011 Oct 5. Neurology. 2011. PMID: 21975201 No abstract available.
Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study.
Khalil M, Langkammer C, Ropele S, Petrovic K, Wallner-Blazek M, Loitfelder M, Jehna M, Bachmaier G, Schmidt R, Enzinger C, Fuchs S, Fazekas F. Khalil M, et al. Neurology. 2011 Nov 1;77(18):1691-7. doi: 10.1212/WNL.0b013e318236ef0e. Epub 2011 Oct 5. Neurology. 2011. PMID: 21975210
Randomized trial of oral teriflunomide for relapsing multiple sclerosis.
O'Connor P, Wolinsky JS, Confavreux C, Comi G, Kappos L, Olsson TP, Benzerdjeb H, Truffinet P, Wang L, Miller A, Freedman MS; TEMSO Trial Group. O'Connor P, et al. N Engl J Med. 2011 Oct 6;365(14):1293-303. doi: 10.1056/NEJMoa1014656. N Engl J Med. 2011. PMID: 21991951 Clinical Trial.
Implication of the Toll-like receptor 4 pathway in the response to interferon-β in multiple sclerosis.
Bustamante MF, Fissolo N, Río J, Espejo C, Costa C, Mansilla MJ, Lizasoain I, Moro MA, Carmen Edo M, Montalban X, Comabella M. Bustamante MF, et al. Ann Neurol. 2011 Oct;70(4):634-45. doi: 10.1002/ana.22511. Ann Neurol. 2011. PMID: 22028223